Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study
Franco Locatelli(Bambino Gesù Children's Hospital), Vanderson Rocha(European Organisation for Rare Diseases), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Jerry Stein(Schneider Children's Medical Center), Lochie Teague(Starship Children's Health), Adrienne B.M. Madureira(Instituto Nacional de Câncer - INCA), Brigitte Strahm(University Medical Center Freiburg), Mary Eapen(Medical College of Wisconsin), Éliane Gluckman(Assistance Publique – Hôpitaux de Paris), Carmem Bonfim(Universidade Federal do Paraná), Tracey O’Brien(Sydney Children's Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Joanne Kurtzberg(Duke University), Alessandro Crotta(European Organisation for Rare Diseases), Ajay Vora(Great Ormond Street Hospital), Annalisa Ruggeri(Inserm), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), John E. Wagner(Kings County Hospital Center), Charlotte M. Niemeyer(University of Freiburg), Marco Zecca(Policlinico San Matteo Fondazione), Margaret L. MacMillan(University of Minnesota Medical Center)
Cited by 99
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738